121 related articles for article (PubMed ID: 37997340)
1. Colonic
Li F; Chen D; Chen J; Nie L
Int J Surg Pathol; 2023 Nov; ():10668969231214808. PubMed ID: 37997340
[TBL] [Abstract][Full Text] [Related]
2. Colon adenoma and adenocarcinoma with clear cell components - two case reports.
Oyama Y; Nishida H; Kusaba T; Kadowaki H; Arakane M; Okamoto K; Wada J; Urabe S; Daa T
Diagn Pathol; 2019 May; 14(1):37. PubMed ID: 31077226
[TBL] [Abstract][Full Text] [Related]
3. Clear cell change in colonic tubular adenoma and corresponding colonic clear cell adenocarcinoma is associated with an altered mucin core protein profile.
Shi C; Scudiere JR; Cornish TC; Lam-Himlin D; Park JY; Fox MR; Montgomery EA
Am J Surg Pathol; 2010 Sep; 34(9):1344-50. PubMed ID: 20697252
[TBL] [Abstract][Full Text] [Related]
4. Colonic clear cell adenocarcinoma with enteroblastic differentiation.
Shiratori Y; Suzuki K; Ikeya T
Clin J Gastroenterol; 2020 Dec; 13(6):1196-1199. PubMed ID: 32803644
[TBL] [Abstract][Full Text] [Related]
5. Ureteral Metastasis of Colonic Adenocarcinoma with Enteroblastic Differentiation: A Rare Case to be Distinguished from Clear Cell Adenocarcinoma of the Urinary Tract.
Minato H; Yoshikawa A; Tsuyama S; Katayanagi K; Hayashi K; Sakimura Y; Bando H; Hori T; Kito Y
Int J Surg Pathol; 2023 Dec; 31(8):1553-1558. PubMed ID: 36895103
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic and immunohistochemical study of small apparently "de novo" colorectal adenocarcinomas.
Hornick JL; Farraye FA; Odze RD
Am J Surg Pathol; 2007 Feb; 31(2):207-15. PubMed ID: 17255765
[TBL] [Abstract][Full Text] [Related]
7. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
McCluggage WG; Shah R; Connolly LE; McBride HA
Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
[TBL] [Abstract][Full Text] [Related]
8. Mucin phenotypes and clinicopathological features of colorectal adenocarcinomas: Correlation with colorectal adenocarcinoma with enteroblastic differentiation.
Kurosawa T; Murakami T; Yamashiro Y; Terukina H; Hayashi T; Saito T; Nojiri S; Sakamoto K; Nagahara A; Yao T
Pathol Res Pract; 2022 Apr; 232():153840. PubMed ID: 35303523
[TBL] [Abstract][Full Text] [Related]
9. Re-evaluation of phenotypic expression in undifferentiated-type early gastric adenocarcinomas using mucin core protein and CDX2.
Ikarashi S; Nishikura K; Ajioka Y; Aoyagi Y
Gastric Cancer; 2013 Apr; 16(2):208-19. PubMed ID: 22829163
[TBL] [Abstract][Full Text] [Related]
10. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems.
Oliva E; Amin MB; Jimenez R; Young RH
Am J Surg Pathol; 2002 Feb; 26(2):190-7. PubMed ID: 11812940
[TBL] [Abstract][Full Text] [Related]
11. Immunophenotypic differences between intestinal-type and low-grade papillary sinonasal adenocarcinomas: an immunohistochemical study of 22 cases utilizing CDX2 and MUC2.
Cathro HP; Mills SE
Am J Surg Pathol; 2004 Aug; 28(8):1026-32. PubMed ID: 15252308
[TBL] [Abstract][Full Text] [Related]
12. Early gastric cancer involving a pure enteroblastic differentiation component that was curatively resected via endoscopic submucosal dissection.
Ikezawa N; Tanaka S; Kaku H; Takao T; Morita Y; Toyonaga T; Komatsu M; Yokozaki H; Ito T; Kodama Y
Clin J Gastroenterol; 2020 Aug; 13(4):512-516. PubMed ID: 32227292
[TBL] [Abstract][Full Text] [Related]
13. The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas.
Kaimaktchiev V; Terracciano L; Tornillo L; Spichtin H; Stoios D; Bundi M; Korcheva V; Mirlacher M; Loda M; Sauter G; Corless CL
Mod Pathol; 2004 Nov; 17(11):1392-9. PubMed ID: 15205684
[TBL] [Abstract][Full Text] [Related]
14. Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus.
Park KJ; Kiyokawa T; Soslow RA; Lamb CA; Oliva E; Zivanovic O; Juretzka MM; Pirog EC
Am J Surg Pathol; 2011 May; 35(5):633-46. PubMed ID: 21490443
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of β-catenin, Ki67, CD3 and CD18 in canine colorectal adenomas and adenocarcinomas.
Herstad KMV; Gunnes G; Rørtveit R; Kolbjørnsen Ø; Tran L; Skancke E
BMC Vet Res; 2021 Mar; 17(1):119. PubMed ID: 33712002
[TBL] [Abstract][Full Text] [Related]
16. The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody.
Bayrak R; Haltas H; Yenidunya S
Diagn Pathol; 2012 Jan; 7():9. PubMed ID: 22268990
[TBL] [Abstract][Full Text] [Related]
17. Metastatic intestinal carcinomas simulating primary ovarian clear cell carcinoma and secretory endometrioid carcinoma: a clinicopathologic and immunohistochemical study of five cases.
Young RH; Hart WR
Am J Surg Pathol; 1998 Jul; 22(7):805-15. PubMed ID: 9669343
[TBL] [Abstract][Full Text] [Related]
18. Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases.
Osunkoya AO; Epstein JI
Am J Surg Pathol; 2007 Sep; 31(9):1323-9. PubMed ID: 17721186
[TBL] [Abstract][Full Text] [Related]
19. Early stage clear cell adenocarcinoma coexisting with tubular adenoma and adenoma with clear cell change in the colon.
Tochio T; Baba Y; Asakawa H; Nose K; Tsuruga S; Kumazawa H; Isono Y; Tanaka H; Matsusaki S; Sase T; Saito T; Okano H; Mukai K; Kushima R
Clin J Gastroenterol; 2021 Apr; 14(2):589-593. PubMed ID: 33420668
[TBL] [Abstract][Full Text] [Related]
20. Primary cervical adenocarcinoma with intestinal differentiation and colonic carcinoma metastatic to cervix: an investigation using Cdx-2 and a limited immunohistochemical panel.
Raspollini MR; Baroni G; Taddei A; Taddei GL
Arch Pathol Lab Med; 2003 Dec; 127(12):1586-90. PubMed ID: 14632574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
